Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | |
Div Cover | n/a | |
Op Mrgn | 1.4% | |
ROCE | 9.8% |
Latest | F'cast | |
---|---|---|
P/E | 529.8 | |
PEG | n/a | |
Pr/Revenue | 3.9 | |
Pr/Book | 4.7 |
Latest | F'cast | |
---|---|---|
Revenue | 14.8% | |
PBT | -62.0% | |
EPS | -94.0% | |
DPS | n/a |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 2,666.70 | (232.22) | (136.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 2,986.27 | 570.44 | 430.00¢ | 17.1 | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 3,394.64 | 529.12 | 153.00¢ | 52.5 | n/a | -64% | n/a | 0.0% |
31-Dec-23 | 3,695.65 | 834.22 | 267.00¢ | 23.5 | 0.3 | +74% | n/a | 0.0% |
31-Dec-24 | 4,241.22 | 316.63 | 16.00¢ | 431.7 | n/a | -94% | n/a | 0.0% |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 4,836.74 | 1,516.25 | 621.73¢ | 13.6 | 0.0 | +3,786% | n/a | 0.0% |
31-Dec-26 | 5,370.37 | 1,863.69 | 732.67¢ | 11.6 | 0.7 | +18% | n/a | 0.0% |
31-Dec-27 | 5,874.20 | 2,278.85 | 884.69¢ | 9.6 | 0.5 | +21% | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
FDA grants EUA for Eli Lilly treatment in conjun... | 20-Nov-2020 | ShareCast |
Currency | US Dollars |
Share Price | $ 84.76 |
Change Today | $ -0.28 |
% Change | -0.33 % |
52 Week High | $86.92 |
52 Week Low | $55.11 |
Volume | 1,643,022 |
Shares Issued | 193.43m |
Market Cap | $16,396m |
RiskGrade | 196 |
Strong Buy | 8 |
Buy | 4 |
Neutral | 11 |
Sell | 2 |
Strong Sell | 0 |
Total | 25 |
Time | Volume / Share Price |
16:00 | 100 @ $84.78 |
15:59 | 176 @ $84.79 |
15:59 | 100 @ $84.79 |
15:59 | 123 @ $84.79 |
15:59 | 100 @ $84.78 |
You are here: research